Bernard Peperstraete, Acuamark Diagnostics - Novel Early Cancer Screening | LSI Europe '24

Find out how we’re unlocking frequent, recurring monitoring for early cancer signal as the new standard of primary care. Learn More: https://acuamarkdx.com/
Join Our Next Event
Partner with the leaders
shaping the future of
Medtech at LSI USA ‘26
March 16th - 20th, 2026
Waldorf Astoria, Monarch Beach
Speakers
Bernard Peperstraete
Bernard Peperstraete
Cofounder & CEO, Acuamark Diagnostics